Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J7503 (Envarsus Xr) Fee Schedule
Last Verified: October 2026
Healthcare providers use this code to document and receive reimbursement for visits that address moderate-level medical decision-making, often including multiple diagnoses or prescription management.
Tacrolimus, extended release, (Envarsus XR), oral, 0.25 mg
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Immunosuppressive Drugs |
| Common Place of Service | 99 - Other POS None |
| Complexity Level | Low |
| Medicaid Fee Schedule | View Medicaid rates for J7503 |
| Medicare Payment Limit | $1.831  |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 68992-3010-01 - ENVARSUS XR 1 MG • 68992-3010-03 - ENVARSUS XR 1 MG • 68992-3040-01 - ENVARSUS XR 4 MG • 68992-3040-03 - ENVARSUS XR 4 MG • 68992-3075-01 - ENVARSUS XR 0.75 MG |
National average reimbursement for HCPCS J7503 by major payers:
$1.85
$1.81
$1.94
$1.87
Compare published rates across providers.
Choose a payer to see a sample of rates for HCPCS J7503.
HCPCS J7503
5 of 25 sample ratesHigher to lower in this preview
Sutter East Bay Hospitals, Sutter Delta Medical Center
Sutter East Bay Hospitals
$27.70Published rateNicholas H. Noyes Memorial Hospital
Nicholas H Noyes Memorial Hospital
$1.90Published rateAllegiance Hospital Of North Little Rock, LLC, North Metro Medical Center
Allegiance Hospital Of North Little Rock LLC
$1.79Published rateStephanie Harris
Cardiology Specialists Of North Texas PLLC
$1.76Published rateBronxcare Health System
$0.92Published rate
Get a free rate benchmark for your specialty.
Choose your state and specialty to build a report from payer-published rates.
Use market rates to prepare your payer proposal.
Payer Contract Negotiation
Draft a fee schedule renegotiation letter.
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J7503 vs. Other Immunosuppressive Drugs Codes
The HCPCS J7503 code is part of the Drugs Administered Other than Oral Method services used for Immunosuppressive Drugs. It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.
The HCPCS J7503 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.
| Code | Complexity | Description |
|---|---|---|
| 68992-3010-01-NDC | Moderate | ENVARSUS XR 1 MG |
| 68992-3010-03-NDC | Moderate | ENVARSUS XR 1 MG |
| 68992-3040-01-NDC | Moderate | ENVARSUS XR 4 MG |
| J7503-HCPCS | Low | Tacrolimus, extended release, (Envarsus XR), oral, 0.25 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J7503. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J7503 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
FREE SAMPLE MARKET COMPARISON
Let's review your payer contracts side-by-side with the market.
Bring your top codes (like HCPCS J7503) and we'll show you how you compare in 15 minutes or less.